Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.
- DOI
- 10.1002/cam4.2966
- Published
- 2020 May
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.2966,
title = {Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.},
author = {Zilli T and Jorcano S and Bral S and Rubio C and Bruynzeel AME and Oliveira A and Abacioglu U and Minn H and Symon Z and Miralbell R},
year = {2020},
journal = {Cancer medicine},
doi = {10.1002/cam4.2966},
url = {https://doi.org/10.1002/cam4.2966}
}RIS
TY - JOUR TI - Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results. AU - Zilli T AU - Jorcano S AU - Bral S AU - Rubio C AU - Bruynzeel AME AU - Oliveira A AU - Abacioglu U AU - Minn H AU - Symon Z AU - Miralbell R PY - 2020 JO - Cancer medicine DO - 10.1002/cam4.2966 UR - https://doi.org/10.1002/cam4.2966 ER -
APA
T, Z., S, J., S, B., C, R., AME, B., A, O., U, A., H, M., Z, S., & R, M. (2020). Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.. Cancer medicine. https://doi.org/10.1002/cam4.2966
Source records
- pubmed · retrieved 2026-09-26T21:11:18.663Z